Multiplicon News RSS

Multiplicom N.V. launches two new kits for cancer predisposition

Wim — Tue, 24 Jan 2012 18:02:58 -0500

read more

BRCA MASTR Assay upgrade to v2.1

Wim — Mon, 10 Oct 2011 03:24:36 -0400

The BRCA MASTR Assay v2.0 was introduced in the first trimester of 2011. Since then numerous users have been working with the assay and provided us with very supportive feedback. We strive, together with our customers, to closely monitor our diagnostic products to enable further improvements.

Monitoring BRCA MASTR assay v2.0 taught us that amplicon BRCA1_ex07_01 had the tendency for low read counts and therefore we decided to implement a solution in which both amplicons for BRCA1 exon 7 are replaced by one 1 amplicon encompassing the entire exon. Consequently the total number of amplicons is now 93, still with 5 multiplex PCR reactions. A detailed data sheet providing more details about the changes made to the version 2.0 can be found HERE.

This BRCA MASTR v2.1 upgrade will completely replace the version 2.0 as of 19 September onwards.

Multiplicom is striving with this improvement to achieve further optimization of your workflow in BRCA testing.

read more

Multiplicom introduces genetic analysis of FAP genes using its MASTR technology

Wim — Mon, 19 Sep 2011 04:31:19 -0400

To identify at-risk individuals for familial adenomatous polyposis colon cancer (FAP), mutation analysis of the APC and MUYTH genes may be performed.
The new FAP MASTR assay targets the full coding exons of the APC and MUYTH genes covering 52 amplicons in total in only 3 PCR multiplexes.

With carefully developed PCR multiplexes and a fixed mixing scheme the amplicon normalization step is readily achieved and your sample-throughput per run can be maximized.

read more

Multiplicom’s symposium: “Accelerated Diagnostics with Next-Gen Sequencing, mastering a Complete Workflow” at ESHG 2011

Wim — Mon, 19 Sep 2011 04:26:16 -0400

You can download the key presentations here:

MASTR technology overview

CFTR MASTR @ IonTorrent

GIMV, VIB and University of Antwerp invest EUR 2.0 million in molecular diagnostics startup Multiplicom

Wim — Mon, 19 Sep 2011 04:06:02 -0400

Gimv, Gimv managed Biotechfonds Vlaanderen, VIB and University of Antwerp (UA) together invest EUR 2.0 million in a Series-A funding round of Multiplicom, a Belgian startup focused on molecular diagnostics. Gimv and Gimv managed funds invest EUR 1.5 million. VIB and UA together invest the balance of EUR 0.5 million.

read more

Multiplicom moves into new facilities.

LucSegers — Tue, 19 Jul 2011 12:13:49 -0400

We gladly announce we have moved into our new facility in Niel. All laboratory and office functions are operational.
We want to inform you our new telephone number; + 32 3 289 14 00.

Wishing you nice holidays.

read more

News from Multiplicom

pronovix_admin — Fri, 28 Nov 2008 07:31:09 -0500

May 2011 : ESHG conference, Amsterdam, Netherlands

May 28th 2011 : ESHG Satellite Symposium "Accelerated diagnostics with next-gen sequencing, mastering a complete workflow"

February 2011 : Techgene & Eurogentest GA meeting, Leuven, Belgium

October 2010 : TechGene Scientific meeting, Utrecht,Netherlands

June 2010 : ESHG conference, Gotheburg, Sweden

April 2010 : commercial launch of the BRCA & CFTR MASTR assays

read more